etoposide has been researched along with Paraproteinemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, I; Gohda, T; Morii, T; Nakano, H; Narita, N; Nishikawa, K; Shimoyama, T; Tsukaguchi, N; Yagi, H | 1 |
| Gale, RP; Kosmo, MA | 1 |
2 other study(ies) available for etoposide and Paraproteinemias
| Article | Year |
|---|---|
[A case of leukemic lymphoma complicated by M-proteinemia: effectiveness of long-term daily administration of oral low-dose etoposide in continuing remission].
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Employment; Etoposide; Humans; Immunoglobulin M; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraproteinemias; Remission Induction | 1999 |
Plasma cell leukemia with IgA paraproteinemia and hyperviscosity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Viscosity; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Heart Failure; Humans; Immunoglobulin A; Leukemia, Plasma Cell; Male; Middle Aged; Paraproteinemias; Plasmapheresis; Prednisone; Vincristine | 1988 |